Last Updated:
Name Designation Appointment Date Status
Sudeep Singh Narula

Appointed as Director since November 2007

 Director 22-Nov-2007 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Genesis Clinical Research Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Prince Pal Singh Bachitr Tuli

Appointed as Director since December 2007

 Director 15-Dec-2007 Current
Preet Mohan Singh Randhawa

Appointed as Director since February 2008

 Director 11-Feb-2008 Current
Jasjit Singh Walia

Appointed as Director since December 2007

 Director 15-Dec-2007 Current

People Timeline

Explore the timeline of key personnel in Genesis Clinical Research Private Limited's leadership journey.

Contact Details
  • Address E-347, Greater Kailash-I, New Delhi Delhi, 110048, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110048
  • Country India
  • Website -
Frequently Asked Questions
You can contact Genesis Clinical Research Private Limited through their registered address at E-347, Greater Kailash-I, New Delhi Delhi, 110048, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Genesis Clinical Research Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SUDEEP SINGH NARULA
  • PREET MOHAN SINGH RANDHAWA
  • JASJIT SINGH WALIA
  • PRINCE PAL SINGH BACHITR TULI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available